NNVC

NANOVIRICIDES INC (NNVC) Is Bouncing Back

 
Shares of NANOVIRICIDES INC (Public, OTC:NNVC) are trying to bouncing back from its recent lows helped by the press release issued by NNVC earlier this week.
 
NNVC stock has moved higher by% to $1.11. Earlier this week, NNVC said that it has been working on developing NV-INF-1 and is planning to submit the same for FDA approval. NNVC said that it has been consulting with its FDA consultants.
 
NNVC expects to get very good response for its products for the treatment of hospitalized patients with severe influenza.
 
NNVC stock had been consolidating within a narrow range of $1.25-$1.10 over the past one month. Over the past one year, The stock has been moving within a range of $0.97-$1.74. NANOVIRICIDES INC (Public, OTC:NNVC) has market capitalization of $159.14 million.
 

NNVC Stock Growing

 
So far this year, NNVC stock underperformed the wider market and slumped over 26%. From the technical prospectus, The stock is trading below its 50-Day Moving Average and 200-Day Moving Average of $1.15 and $1.29 respectively.
 
NNVC had total outstanding shares of 142.09 million, of which 95.59 million shares were floating. The company is a development stage without any revenue as of date.
 
For the latest fiscal year, NNVC had reported loss of $5.82 million or 4 cents a share.The company had cash in hand of $7.76 million.
 
The RSI for NNVC stock is just above 48, showing neutral signal. Both the 12-Day and 26-Day MACD are trading below the power zone. However, MACD histogram is above the “zero.”

More Penny Stock News, IPO Updates and Stock Market Research.

Get NNVC Updats from our FREE eMail List

Related posts:

1. NNVC NNVC Company Profile NNVC, NanoViricides, Inc., (NNVC) was founded in...
2. EMAMBA INTERNATIONAL CORP – EMBA   EMAMBA INTERNATIONAL (EMBA) Continues To Soar   Shares of...

Related posts brought to you by Yet Another Related Posts Plugin.